Patents Assigned to NODUS THERAPEUTICS
  • Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulator
    Patent number: 10603358
    Abstract: The present invention provides a method of treating cancer with an integrin-binding-Fc fusion protein alone or in combination with IL-2 and/or an immune stimulant (i.e., an immune checkpoint stimulator), and/or an immune checkpoint inhibitor. The invention also provides composition for use in such methods.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: March 31, 2020
    Assignee: NODUS THERAPEUTICS
    Inventors: Jennifer R. Cochran, Karl Dane Wittrup
  • Method of treating cancer with a multiple integrin binding Fc fusion protein
    Patent number: 10350266
    Abstract: The present invention provides a method of treating cancer with an integrin-binding-Fc fusion protein alone or in combination with IL-2 and/or an immune checkpoint inhibitor. The invention also provides composition for use in such methods.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: July 16, 2019
    Assignee: NODUS THERAPEUTICS, INC.
    Inventors: Jennifer R. Cochran, Karl Dane Wittrup